OB/GYN Clinical Alert – April 1, 2008
April 1, 2008
View Issues
-
Therapeutic Options for Recurrent Ovarian Cancer Expand
The principal purpose of this clinical study was to evaluate the efficacy of gemcitabine relative to a clinical standard therapy, pegylated liposomal doxorubicin (PLD) in women with ovarian cancer relapsing within a year of primary treatments. -
Reflexology Might Help Treat Detrusor Overactivity
One hundred and twenty subjects with symptoms of idiopathic detrusor overactivity (OAB) were recruited to evaluate the efficacy of reflexology compared to nonspecific foot massage. -
Sentinel Node Concept Applies for Vulva Cancer
Sentinel node localization and sampling has become a standard practice in the evaluation of regional nodal status for patients with breast cancer and cutaneous melanoma. -
Vaginal birth after Cesarean Section Revisited — 2008
In a previous Clinical Alert, the risk of uterine rupture in patients attempting vaginal birth after cesarean sections (VBACs) was addressed when it appeared that there was a distinct downturn in the amount of VBACs being done in the USA. -
WHI Follow-Up Report
The Women's Health Initiative investigators reported health outcomes at 3 years after the estrogen-progestin arm of the clinical trial was canceled. -
Pharmacology Watch: Erythropoietin and Cancer Death Rates
In this issue: Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives? -
Clinical Briefs in Primary Care supplement